Clinical evaluation

Key Takeaways

Clinical evaluation is a systematic, ongoing process mandated by EU MDR 2017/745 to assess device safety and performance throughout its lifecycle.

A Clinical Evaluation Report (CER) must document clinical data, risk-benefit analysis, and state-of-the-art equivalence to support CE marking and notified body submission.

Clinical evaluation differs from clinical investigation: Evaluation uses existing data (literature, registry, expert opinion), while investigation requires new prospective studies.

Practice management software like Pabau keeps patient consent forms, intake records, and compliance documentation organized in one system for the practices using these devices day to day.

Medical device manufacturers face a regulatory mandate: Prove your device is safe and effective before it reaches patients. Under EU Medical Device Regulation (MDR) 2017/745, this proof comes through clinical evaluation: a systematic, evidence-based assessment that underpins every CE marking application, notified body submission, and post-market surveillance plan.

Small to mid-size device companies in particular often struggle with the complexity: What data do you need? How do you organize it? When is clinical evaluation complete?

Device risk varies widely. A Class III implant carries a heavier evidentiary bar than a Class I bandage, but every device needs a documented clinical evaluation before it reaches the market.

Aesthetic devices such as IPL and laser systems, common in laser clinics, typically fall in the Class IIa or IIb range and follow the same core CER structure as higher-risk devices.

This guide walks you through the clinical evaluation process from start to finish, with a downloadable template to structure your documentation and a checklist to verify compliance before notified body review.

Whether you’re a regulatory affairs professional, a quality manager, or a clinical team lead, understanding the clinical evaluation lifecycle is essential to successful device approval in the EU and equivalent jurisdictions.

What is a clinical evaluation?

Clinical evaluation is a proactive, systematic appraisal of clinical data to determine whether a medical device is safe and performs as intended for its stated indications and patient population. It is not a one-time event but an ongoing process that begins during device design, intensifies during pre-market assessment, and continues after the device reaches the market through post-market surveillance.

Under EU MDR Article 61, clinical evaluation is mandatory for all medical devices seeking CE marking. The evaluation documents the clinical evidence that the device meets its safety and performance claims, a critical step for regulatory approval and notified body acceptance.

• Assesses device safety, performance, and effectiveness
• Evaluates risk-benefit profile relative to state-of-the-art equivalents
• Documents intended purpose and clinical indications
• Identifies ongoing post-market surveillance needs

The output of clinical evaluation is the Clinical Evaluation Report (CER), a comprehensive technical and scientific document that manufacturers submit to notified bodies as part of their conformity assessment dossier.

Clinical evaluation vs. clinical investigation: Key differences

These two terms are often confused, yet they represent distinct regulatory activities with different timelines, data sources, and triggers.

A device may require clinical investigation if existing clinical evidence is insufficient to support safety and performance claims. Investigation results then feed into the clinical evaluation, strengthening the overall evidence dossier.

EU MDR requirements for clinical evaluation

EU MDR 2017/745 makes clinical evaluation a mandatory cornerstone of the conformity assessment procedure. The regulation mandates that manufacturers maintain an up-to-date Clinical Evaluation Report and undergo periodic review to capture new clinical data and emerging safety signals.

• Continuous process: Clinical evaluation begins at device design and continues throughout market life. Update frequency is risk-based: Class III and implantable devices, including breast implants used in plastic surgery practices, need CER review at least annually, while Class I, IIa, and IIb devices are typically reviewed every 2-5 years, or sooner if significant new data or safety signals emerge
• MEDDEV 2.7/1 Rev 4 guidance: The European Commission’s guidance document sets out the methodology for conducting systematic literature reviews and appraising clinical data. The same clinical documentation habits apply whether you’re writing a CER or a routine treatment note
• Notified body submission: The CER is a core component of the technical documentation dossier that notified bodies review for CE marking assessment
• Post-market obligation: Manufacturers must update the CER based on post-market clinical follow-up (PMCF) data and adverse event reports

Non-compliance with clinical evaluation requirements can result in regulatory action, device suspension, or market withdrawal.

The clinical evaluation process: Step-by-step

Clinical evaluation unfolds across four key phases, each documented in its own section of the CER.

1. Clinical evaluation plan (CEP) scoping: Define the device’s intended purpose, patient population, clinical claims, and data collection strategy. Identify which clinical evidence sources (literature, registries, expert opinion) will support safety and performance assessment.
2. State-of-the-art review: Conduct a systematic search of equivalent devices and treatments in the medical literature. Document how your device’s safety and performance profile compares to existing standards.
3. Clinical data appraisal: Evaluate the quality and relevance of identified clinical data using structured critical appraisal tools. Assess bias, applicability, and strength of evidence.
4. Risk-benefit analysis: Weigh the clinical benefits of your device against identified risks across the intended patient population and use conditions.

These steps culminate in the Clinical Evaluation Report, which synthesizes findings and supports the regulatory claim that the device meets its safety and performance objectives.

Key components of a clinical evaluation report

A robust CER includes six core sections that manufacturers must complete to satisfy notified body expectations and EU MDR requirements.

• Device description and intended use: Detailed specification of the device, its technical characteristics, and its intended clinical indications and patient population
• Clinical evaluation plan: The systematic review methodology and documentation templates used to identify and appraise clinical evidence
• State-of-the-art review: Analysis of equivalent devices and treatments, demonstrating how your device compares clinically
• Clinical data appraisal: Systematic evaluation of identified clinical literature and evidence, with documented quality assessment
• Risk-benefit analysis: Documented assessment of clinical risks versus benefits relative to intended use and patient population
• Clinical evaluation conclusion: Summary statement supporting the safety and performance claims and conformity assessment

Each section must reference supporting documentation (literature abstracts, data extraction forms, appraisal checklists) that notified bodies review during pre-market assessment.

How to use the clinical evaluation template

The downloadable Clinical Evaluation template is structured around the six core CER sections outlined above. Here’s how to complete it.

1. Complete the device description section: Fill in your device name, classification, intended use statement, indications for use, and patient population. Link this section to your technical documentation and instructions for use.
2. Document the evaluation plan: Define your clinical evaluation strategy, including which data sources you will search (PUBMED, EMBASE, device registries, expert consensus documents), your evidence inclusion/exclusion criteria, and your systematic review methodology.
3. Conduct the state-of-the-art review: Search the medical literature for equivalent devices and treatments. Document search terms, databases queried, and results in a structured table, using the same format each time so extracted data stays consistent across reviewers.
4. Appraise clinical data: For each identified piece of clinical evidence (study, case report, registry analysis), complete a data extraction and quality appraisal form. Document bias risk, applicability to your device, and strength of evidence.
5. Perform risk-benefit analysis: List identified device risks (mechanical, electrical, biological, clinical) and corresponding clinical benefits. Score each against your intended patient population and use conditions.

Clinical evaluation checklist: Before you submit

Before sending your Clinical Evaluation Report to your notified body, run through this pre-submission checklist to verify that all required sections are complete and meet regulatory expectations.

• Device description section is complete with classification, indications, and patient population clearly stated
• Clinical Evaluation Plan documents your systematic review strategy and evidence selection criteria
• State-of-the-art review identifies at least 3-5 equivalent devices or treatments with documented comparison to your device
• Clinical data appraisal includes quality assessment of all identified studies using a recognized tool (GRADE, Cochrane bias risk, AHRQ)
• Risk-benefit analysis documents all known risks, corresponding clinical benefits, and net benefit conclusion for the intended population
• CER conclusion clearly states that clinical evaluation demonstrates safety and performance consistent with the device’s intended use
• All referenced documents (literature abstracts, appraisal forms, search strategies) are attached as supporting annexes
• Quality review: CER is reviewed by a second qualified individual (regulatory affairs, clinical, quality) before submission
• Notified body pre-submission: For complex or novel devices, consider requesting an informal pre-submission meeting with your notified body to clarify expectations before formal dossier submission

Keep patient records and consent forms organized

Practice management software like Pabau centralizes patient consent forms, treatment documentation, and compliance records in one system, cutting the administrative load of tracking paperwork by hand.

Book a demo

Post-market clinical follow-up (PMCF) and ongoing evaluation

Clinical evaluation does not end at CE marking. Under EU MDR Annex XIV Part B, manufacturers must establish a Post-Market Clinical Follow-up (PMCF) plan that collects clinical data on device performance and safety after market release.

The PMCF plan documents how your company will systematically collect, analyze, and report post-market clinical data. As with the initial CER, update frequency is risk-based: Annually for Class III and implantable devices, and every 2-5 years for other risk classes, or sooner if new clinical evidence, adverse event trends, or safety signals emerge.

This ongoing process ensures that clinical evaluation remains current and supports regulatory compliance throughout the device’s market life.

The CER itself is the manufacturer’s responsibility, but practices using these devices day to day handle a separate layer of compliance recordkeeping. Many rely on their own compliance management tools to track consent, treatment documentation, and audit trails, distinct from the manufacturer’s PMCF obligations.

Conclusion

Clinical evaluation is a non-negotiable regulatory requirement for medical device approval in the EU and equivalent jurisdictions. It demonstrates that your device is safe, performs as claimed, and carries an acceptable risk-benefit profile for its intended patients.

The downloadable template above gives you a structured framework for documenting your clinical evaluation. Use it to organize your evidence, standardize your appraisal methodology, and speed up notified body review.

For practices handling day-to-day patient consent, documentation, and compliance records, practice management software like Pabau keeps intake forms, signed consents, and compliance records in one system. Book a demo to see how Pabau’s digital forms and documentation tools can help your practice stay organized.

Continue your research

Need another structured clinical template? Discharge plan template follows the same document-once, reuse-often structure for patient discharge documentation.

Documenting care over time? Dysphagia care plan template shows how to structure an ongoing clinical monitoring record.

Tracking patient baselines by age? Cholesterol level chart is a ready-made reference for logging values against age-based norms.

Frequently asked questions